A tumor sample with a new mutation of exon 59 of NRAS oncogene (as present in exon 59 of KRAS oncogene) would therefore produce a low correlation coefficient, allowing the operator to detect this unusual sample. This evidence concerns the gene KRAS and neoplasm.